CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −1,592 | $37.44 | $60K | 192,079 |
| 2026-07-16 | GILLIS JONATHAN CAO and Interim CFO | Sale 10b5-1 | −6,979 | $36.66 | $256K | 164,185 |
| 2026-07-16 | GILLIS JONATHAN CAO and Interim CFO | Sale 10b5-1 | −1,476 | $37.44 | $55K | 162,709 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −9,163 | $36.46 | $334K | 308,441 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −5,865 | $37.26 | $219K | 302,576 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −19 | $37.96 | $721 | 302,557 |
| 2026-07-16 | Hanson Kristopher General Counsel | Sale | −4,776 | $36.45 | $174K | 150,295 |
| 2026-07-16 | Hanson Kristopher General Counsel | Sale | −3,331 | $37.26 | $124K | 146,964 |
| 2026-07-16 | Hanson Kristopher General Counsel | Sale | −11 | $37.96 | $418 | 146,953 |
| 2026-07-16 | Lillie James Woodruff Chief Scientific Officer | Sale | −5,009 | $36.45 | $183K | 230,077 |
| 2026-07-16 | Lillie James Woodruff Chief Scientific Officer | Sale | −3,526 | $37.26 | $131K | 226,551 |
| 2026-07-16 | Lillie James Woodruff Chief Scientific Officer | Sale | −12 | $37.96 | $456 | 226,539 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −40,899 | $36.46 | $1.5M | 1,291,417 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −28,091 | $37.26 | $1.0M | 1,263,326 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −92 | $37.96 | $3K | 1,263,234 |
| 2026-07-15 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −5,545 | $36.13 | $200K | 205,645 |
| 2026-07-15 | Kreitzer Anatol Chief Discovery Officer | Sale 10b5-1 | −4,510 | $36.94 | $167K | 201,135 |
| 2026-07-15 | GILLIS JONATHAN CAO and Interim CFO | Sale 10b5-1 | −5,356 | $36.13 | $194K | 175,863 |
| 2026-07-15 | GILLIS JONATHAN CAO and Interim CFO | Sale 10b5-1 | −4,699 | $36.94 | $174K | 171,164 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −7,155 | $36.16 | $259K | 338,904 |
Page 3 of 12 · 239 trades